Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

ENTERO HEALTHCARE SOLUTIONS LTD.

NSE : ENTEROBSE : 544122ISIN CODE : INE010601016Industry : TradingHouse : Private

BSE1098.00-30.1 (-2.67 %)

PREV CLOSE ( ) 1128.10

OPEN PRICE ( ) 1121.80

BID PRICE (QTY) 1098.00 (11)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 2770

TODAY'S LOW / HIGH ( )1080.00 1152.20

52 WK LOW / HIGH ( )974.45 1258

NSE1096.00-34.35 (-3.04 %)

PREV CLOSE( ) 1130.35

OPEN PRICE ( ) 1135.95

BID PRICE (QTY) 1096.00 (12)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 55935

TODAY'S LOW / HIGH( ) 1078.15 1146.65

52 WK LOW / HIGH ( )970 1258

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 10-01 2018

Management Info

Sujesh Vasudevan - Chairman Prabhat Agrawal - Managing Director

Registered Office

Address Plot No. I-35, Building - B,Industrial Area Phase - I,13/7 Mathura Road,
Faridabad,
Haryana-121003

Phone

Email jayant.prakash@enterohealthcare.com

Website www.enterohealthcare.com

Registrars Details

Link Intime India Pvt Ltd.

C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai

Listing : BSE, NSE

NEWS

13Mar Substantial Acquisition of Shares
Inter alia, approved:- 1) Acquisition of balance 12,00,000 Equity Shar..

11Mar Macrotech Developers, Tata Technologie
Macrotech Developers has raised Rs 3,300 crore by selling shares to inst..

11Mar Appointment Of Ernst & Young (EY) LLP
Appointment of Ernst & Young (EY) LLP as Internal Auditor of the Company

09Mar Entero Healthcare Solutions gets nod t
Entero Healthcare Solutions has received approval to acquire balance 12,..

09Mar Entero Healthcare inform about investo
Entero Healthcare has informed about disclosure of Investor conference s..

Financials

Rs. in Millions

	QTR Dec 23	ANNUAL
Net Profit	9.47000000000009
Gross Profit	6.98000000000009
Operating Profit	77.5200000000001
Net Sales

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

The Yamuna Syndicate (BSE) 27201.00 (0.65%)	M.Cap ( in Cr)836.06
TCI Industries (BSE) 1409.00 (4.19%)	M.Cap ( in Cr)126.36
Novartis (BSE) 1059.00 (1.91%)	M.Cap ( in Cr)2614.76
Manbro Industries (BSE) 726.20 (1.99%)	M.Cap ( in Cr)36.39
Manoj Ceramic (BSE) 138.15 (9.99%)	M.Cap ( in Cr)115.13

Shareholding Pattern

	PROMOTERS	52.44%
	NON-INSTITUTION	21.99%
	FI/BANKS/INSURANCE	1.13%
	MUTUAL FUNDS/UTI	0%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
No Data Found

Risk Disclosures on Derivatives

Smart Quotes

ENTERO HEALTHCARE SOLUTIONS LTD.